FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Immunocore Kimmtrak Recall

KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0

IMMUNOCORE, LLC · Conshohocken, PA

Risk level
Class II
Reported by FDA
Sep 10, 2025
Recall ID
D-0614-2025
Check your lot numberHow we source this data

Summary

Immunocore recalled Kimmtrak starting Jun 10, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0614-2025 on Sep 10, 2025. Reason: Subpotent Drug. Status: Ongoing.

Why it was recalled

Subpotent Drug

Product description

KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kingdom, For: Immunocore Commercial LLC, 181 Washington St, Conshohocken, PA, 19428, Product of Denmark NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026

Lot numbers, UPCs & expiration codes

NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026

Where it was sold

US Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0614-2025
Classification
Class II
Status
Ongoing
Recall initiated
Jun 10, 2025
FDA report date
Sep 10, 2025
Quantity
7,572 vials
Recall type
Voluntary: Firm initiated
Recalling firm
IMMUNOCORE, LLC

Original FDA data

Every field from FDA enforcement report D-0614-2025, exactly as published.

Show all FDA fields
City
Conshohocken
State
PA
Status
Ongoing
Country
United States
Event ID
97329
Address
Six Tower Bridge
Address (line 2)
181 Washington St Ste 540
Code information
NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026
Postal code
19428-2068
Report date
Sep 10, 2025
Product type
Drugs
Recall number
D-0614-2025
Classification
Class II
Recalling firm
IMMUNOCORE, LLC
Product quantity
7,572 vials
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kingdom, For: Immunocore Commercial LLC, 181 Washington St, Conshohocken, PA, 19428, Product of Denmark NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026
Distribution pattern
US Nationwide
Recall initiation date
Jun 10, 2025
Center classification date
Sep 3, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0614-2025, published Sep 10, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls